Michele Caraglia

发表

What is the purpose of launching the Translational Medicine Reports journal

Vittorio Gentile, Michele Caraglia, 2017 .

Peptide Functionalization of Silicon for Detection and Classification of Prostatic Cells

Ilaria Rea, Jane Politi, Luca De Stefano, 2017, J. Sensors.

Synergistic Antitumor Activity of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib and IFN-α in Head and Neck Cancer Cells In vitro and In vivo

Michele Caraglia, Pierosandro Tagliaferri, Antonio Avallone, 2006, Clinical Cancer Research.

The novel role of pyrvinium in cancer therapy

Amirhossein Sahebkar, Michele Caraglia, Elham Abdollahi, 2018, Journal of cellular physiology.

Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures

Michele Caraglia, Paolo Grieco, P. Grieco, 2013, Journal of amino acids.

Emerging pathways as individualized therapeutic target of multiple myeloma

Michele Caraglia, Pierosandro Tagliaferri, Pierfrancesco Tassone, 2013, Expert opinion on biological therapy.

Short-Term Diet and Moderate Exercise in Young Overweight Men Modulate Cardiocyte and Hepatocarcinoma Survival by Oxidative Stress

Giovanni Messina, Michele Caraglia, M. Caraglia, 2014, Oxidative medicine and cellular longevity.

Micrornas in prostate cancer: an overview

Gerardo Botti, Michele Caraglia, G. Botti, 2017, Oncotarget.

Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study

Mario Cannataro, Pietro Hiram Guzzi, Mariamena Arbitrio, 2011, Cancer biology & therapy.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Differential transcriptional response to cisplatinum in BRCA1-defectiveversusBRCA1-reconstituted breast cancer cells by microarrays.

Mario Cannataro, Pietro Hiram Guzzi, Pierangelo Veltri, 2009 .